Consumer Law LibrarySearchBy decadeBy respondentBy topicBy outcomeDataAbout

Linde AG

Volume 167 · 167 F.T.C. 930

Citation
167 F.T.C. 930
Docket
C-4660
Decision
2019-02-19
Document type
other
Case type
antitrust
Industry
industrial gases
Outcome
other
Relief
divestiture
Source
Original volume PDF
Original PDF
This decision as a PDF

merger acquisition

Cite this decision

Linde AG, 167 F.T.C. 930 (2019). Consumer Law Library, https://consumerlawlibrary.org/decisions/v167-0023

Report an error in this record (decision id v167-0023)

Order status: unknown. Sunset may be extended by the latest qualifying federal-court complaint alleging an order violation; complaints, dismissal/appeal outcomes, and respondent-specific extensions are not fully tracked.

Cited by 0 later FTC decisions

Cites

Text (OCR of the scan at left; may contain errors)

IN THE MATTER OF LINDE AG, PRAXAIR, INC., AND LINDE PLC Docket No. C-4660. Order, February 19, 2019 Letter approving the petition of Linde AG, Praxair, Inc., and Linde PLC to divest certain gases assets to LyondellBassell Acetyls, LLC.

LETTER ORDER APPROVING DIVESTITURE OF CERTAIN ASSETS Thomas McGrath Linklaters LLP Re: In the Matter of Linde AG, Praxair, Inc., and Linde PLC, Docket No. C-4660. Dear Mr. McGrath:

This is in reference to the petition for the approval of the proposed divestiture of certain assets filed by Linde AG, Praxair, Inc., and Linde PLC (collectively "Linde") and received on Dec member 19, 2018 ("Petition"). Pursuant to the Decision and Order in Docket No. C -4660, Linde requests prior Commission approval of its proposal to divest certain gases assets to LyondellBasell Acetyls, LLC ("Lyondell").

After consideration of Linde's Peti tion and other available information, the Commission has determined to approve the proposed divestiture as set forth in the Petition. In according its approval, the Commission has relied upon the information submitted and the representations made by Linde and Lyondell in connection with the Petition and has assumed them to be accurate and complete.

By direction of the Commission, Commissioner Chopra abstaining. IMPAX LABORATORIES, INC. 931 Interlocutory Orders, Etc.

← 167 F.T.C. 929 · 167 F.T.C. 931 →